2,2,6,6-Tetramethylpiperidin-4-one hydrochloride, 95.0%, 25g

4-(Trifluoromethyl)tetrahydro-2H-pyran-4-amine hydrochloride, 95%, 50mg

H-Ser-OMe.HCl, 98%, 500g

2-(But-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 10g

Anhídrido propiónico, mínimo 98,5 %, para síntesis, 500 ml, envase de vidrio

1-[3-(3-fluorophenyl)-1,2,4-thiadiazol-5-yl]piperazine, 95.0%, 2g

ethyl 1-isopropyl-5-methyl-1H-pyrazole-3-carboxylate, 95.0%, 1g

(R)-4,4-difluoropyrrolidine-2-carboxamide hydrochloride, 98%, 100mg

3-(tert-Butyl)-1-(p-tolyl)-1H-thieno[2,3-c]pyrazole-5-carboxylic acid, 97%, 100mg

Gemcitabine hydrochloride, 98.0%, 50g

(1R,2S)-1-tert-Butyl 2-ethyl cyclohexane-1,2-dicarboxylate, 95.0%, 1g

Botella de boca ancha, 125 ml, 48-400, 24 Pieza(s)

Báscula analítica y de precisión Serie Secura® Modelos estándar, no certificados, 0,001 g, 510 g, 513-1S (W)